Online United States of America
Visionaries within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies.
Johnson & Johnson Innovation is proud to be among those answering the call to prioritize pediatric care, a message widely celebrated at the 2018 State of the Union address alongside the promise of an additional $500 million in government funding for pediatric oncology research over the next 10 years.
In addition to welcoming the awardees in this QuickFire Challenge upon opening in 2020, JLABS @ Washington, DC offers residency to pharmaceutical, medical device, consumer and health technology companies that are aiming to advance the development of new drugs, medical devices, precision diagnostics and health technologies.
Areas of Interest
We encourage applications from innovators working in all aspects of pediatric oncology, pediatric surgical care, and influenza. Specific areas of focus include:
- Innovations in pediatric oncology port technologies
- Drugs that target pediatric-specific driver genes
- Bedside, rapid tumor genetic testing
Pediatric Surgical Care
- Pediatric-specific implants for trauma & fracture care including growth-enabling spine & trauma orthopedic implants
- Innovative treatment options for adolescent idiopathic scoliosis
- Surgical robotics to treat pediatric patients
- Pediatric-focused innovations in influenza
- Novel solutions for influenza vaccine delivery
- Influenza pre-exposure including antivirals prophylaxis formulation
Applications will be accepted across:
- Medical devices
- Consumer products
- Global public health
- Health technologies
- Cross-sector initiatives (an integration of one or more areas of focus mentioned above)
Why This Challenge Matters To Us
Developing safe and effective medicines, devices or consumer products that enable future generations to reach their full potential requires children-centric innovation. The Child Health Innovation Leadership Department (CHILD), an affiliate of Johnson & Johnson Innovation, is a dedicated team working to understand the safety and effectiveness of our medicines in children, and to accelerate policies driven by the needs of our youngest patients.
We collaborate with an aim to change the paradigm for pediatric medical research to enable better-informed decisions by regulators and healthcare practitioners so all children can live longer, healthier and happier lives.
We believe a good idea can come from anywhere, and it’s our goal to find new and innovative technologies that have the potential to provide solutions to patients from across the world. Working together, we can spark the next great idea that can change the trajectory of health for children.
Opportunity is About:
Candidates should be from:
Description of Ideal Candidate:
What we're looking for
Submissions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
- Potential impact
- Uniqueness of solution & level of competition in the current market
- Quality & feasibility of the technology
- Team credibility & capabilities
- Plans for utilizing JLABS @ Washington, DC
- Idea submission outlines interest in the innovation ecosystem in Washington, D.C.
Deadline: February 07, 2020
Cost/funding for participants:
Rewards and benefits
- Up to $150,000 in total grant funding
- One year of residency at JLABS @ Washington, DC with the use of a bench, workstation and access to the JLABS @ Washington, DC community for one year
- Mentoring by the Johnson & Johnson Family of Companies